Physician profile
Jefy M Mathew
NPI 1083602080
$317,583.25
in general payments reported to CMS, 2019-2025
48 companies · $2,037 in 2025
The $2,037 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $85K · 2021: $28K · 2022: $49K · 2023: $70K · 2024: $44K · 2025: $2,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $101K · Food and Beverage: $11K · Travel and Lodging: $3,392 · Education: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101,075.00 |
| Food and Beverage | $11,041.73 |
| Travel and Lodging | $3,391.85 |
| Education | $291.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $297,187.51 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Electromed, INC. | $5,246.13 | 2022-2025 | Smartvest |
| Viiv Healthcare Company | $4,000.00 | 2019 | |
| Genzyme Corporation | $2,656.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,022.76 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Actelion Pharmaceuticals US, INC. | $919.17 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Abbvie INC. | $887.54 | 2022-2024 | |
| Inspire Medical Systems, INC. | $722.27 | 2021-2025 | Inspire |
| Insmed, INC. | $591.31 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $582.70 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $565.75 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.16 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Merck Sharp & Dohme LLC | $302.68 | 2019-2025 | Keytruda, Winrevair, Zerbaxa |
| Jazz Pharmaceuticals INC. | $210.42 | 2020-2025 | |
| Amgen INC. | $208.47 | 2022-2025 | Tezspire |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $201.25 | 2019-2022 | |
| Zoll Respicardia, INC. | $180.41 | 2021 | |
| Pulmonx Corporation | $169.86 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Genentech USA, INC. | $158.01 | 2019-2025 | Xolair |
| Philips North America LLC | $133.02 | 2019-2025 | Vest Therapy Und |
| United Therapeutics Corporation | $122.80 | 2022-2025 | Tyvaso |
| Harmony Biosciences LLC | $111.65 | 2023-2025 | Wakix |
| Melinta Therapeutics, LLC | $109.54 | 2022 | |
| Ekos Corporation | $107.65 | 2019 | |
| Gilead Sciences, INC. | $101.43 | 2019-2024 | |
| Outset Medical INC | $93.78 | 2019 | |
| Viatris Specialty LLC | $79.68 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $65.80 | 2023-2025 | |
| Grifols USA, LLC | $64.24 | 2019-2022 | |
| Pfizer INC. | $55.85 | 2022-2023 | |
| Axsome Therapeutics, INC. | $42.40 | 2024-2025 | Sunosi |
| Shire North American Group INC | $32.04 | 2019 | |
| Paratek Pharmaceuticals, INC. | $30.30 | 2023 | Nuzyra |
| Teva Pharmaceuticals USA, INC. | $28.52 | 2019-2023 | Airduo Digihaler |
| Inogen, INC. | $27.20 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Baxter Healthcare | $27.19 | 2022 | |
| Ani Pharmaceuticals, INC. | $24.29 | 2023 | Purified Cortrophin Gel |
| Allergan, INC. | $24.28 | 2020 | |
| Mallinckrodt Hospital Products INC. | $21.71 | 2022 | |
| Abbott Laboratories | $21.32 | 2022 | |
| Ethicon INC. | $20.48 | 2023 | Monarch Platform |
| Optinose US, INC. | $18.35 | 2023 | |
| Sunovion Pharmaceuticals INC. | $18.09 | 2019 | |
| Tactile Systems Technology INC | $15.45 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.66 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.96 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.07 | 2022 | |
| Ethicon US, LLC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefy Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.